PCVXHealthcareMid-Cap
Vaxcyte, Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Vaxcyte, Inc. (PCVX), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Are PCVX insiders buying or selling?
Vaxcyte, Inc. insiders reported 4 open-market buys ($20.7M) and 206 sells ($135.3M) across 210 Form 4 filings — a net selling position of $114.6M.
Source: SEC EDGAR Form 4
Key Statistics (as of Jul 6, 2026)
Total Form 4 filings
210
SEC EDGAR
Insider filers
17
Insider buys (4)
$20.7M
Insider sells (206)
$135.3M
Insider sentiment
Net sellingNet insider flow of $114.6M in net selling.
Recent PCVX insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 6, 2026 | Andrew Guggenhime | PRESIDENT AND CFO | Sale | 10.0K | $57.28 | $572.8K |
| Jul 6, 2026 | Jim Wassil | CHIEF OPERATING OFFICER | Sale | 2.3K | $56.33 | $126.7K |
| Jun 26, 2026 | Grant Pickering | CHIEF EXECUTIVE OFFICER | Sale | 24.2K | $55.22 | $1.3M |
| Jun 19, 2026 | Grant Pickering | CHIEF EXECUTIVE OFFICER | Sale | 24.5K | $52.50 | $1.3M |
| Jun 19, 2026 | Andrew Guggenhime | PRESIDENT AND CFO | Sale | 10.0K | $53.00 | $530.0K |
| Jun 3, 2026 | Jim Wassil | CHIEF OPERATING OFFICER | Sale | 2.3K | $49.52 | $111.4K |
| May 1, 2026 | Jim Wassil | CHIEF OPERATING OFFICER | Sale | 2.3K | $56.83 | $127.9K |
| Apr 8, 2026 | Elvia Cowan | SVP, Finance & CAO | Sale | 3.0K | $60.00 | $180.0K |
| Apr 3, 2026 | Jim Wassil | CHIEF OPERATING OFFICER | Sale | 2.3K | $58.43 | $131.5K |
| Mar 18, 2026 | Elvia Cowan | SVP, Finance & CAO | Sale | 1.9K | $55.57 | $105.1K |
| Mar 11, 2026 | Elvia Cowan | SVP, Finance & CAO | Sale | 2.5K | $58.59 | $146.5K |
| Mar 11, 2026 | Jim Wassil | CHIEF OPERATING OFFICER | Sale | 7.4K | $58.88 | $435.4K |
| Jan 2, 2026 | Harpreet S. Dhaliwal | Chief Technical Ops Officer | Sale | 9.7K | $46.69 | $454.9K |
| Dec 29, 2025 | Elvia Cowan | SVP, FINANCE | Sale | 11.6K | $47.92 | $557.0K |
| Mar 7, 2025 | Mikhail Eydelman | SVP, GEN COUNSEL & CORP SEC | Sale | 5.0K | $70.74 | $353.7K |
| Mar 4, 2025 | Jim Wassil | CHIEF OPERATING OFFICER | Sale | 8.0K | $73.27 | $586.2K |
| Feb 19, 2025 | Andrew Guggenhime | PRESIDENT AND CFO | Sale | 8.0K | $83.85 | $670.8K |
| Feb 7, 2025 | Mikhail Eydelman | SVP, GEN COUNSEL & CORP SEC | Sale | 5.0K | $90.07 | $450.4K |
| Feb 5, 2025 | Jim Wassil | CHIEF OPERATING OFFICER | Sale | 8.0K | $86.22 | $689.8K |
| Jan 22, 2025 | Andrew Guggenhime | PRESIDENT AND CFO | Sale | 8.0K | $86.51 | $692.1K |
| Jan 17, 2025 | Teri Loxam | Director | Sale | 6.3K | $85.11 | $532.0K |
| Jan 7, 2025 | Mikhail Eydelman | SVP, GEN COUNSEL & CORP SEC | Sale | 5.0K | $85.58 | $427.9K |
| Jan 3, 2025 | Jim Wassil | CHIEF OPERATING OFFICER | Sale | 8.0K | $83.66 | $669.3K |
| Dec 19, 2024 | Andrew Guggenhime | PRESIDENT AND CFO | Sale | 8.0K | $88.78 | $710.2K |
| Dec 10, 2024 | Grant Pickering | CHIEF EXECUTIVE OFFICER | Sale | 2.4K | $92.25 | $218.3K |
Showing the 25 most recent of 210 Form 4 filings for Vaxcyte, Inc..
Most active PCVX insiders
- Grant Pickering56 filings
- Jim Wassil33 filings
- Andrew Guggenhime31 filings
- Jeff Fairman20 filings
- Mikhail Eydelman18 filings
Ask anything about PCVX insider activity
Use Trabud's AI agent to query Vaxcyte, Inc.'s Form 4 history in plain English — "Show me PCVX CEO purchases this year" or compare it against any other ticker.
Open the AI agentPCVX insider trading FAQ
Are Vaxcyte, Inc. insiders buying or selling?
Across 210 SEC Form 4 filings, Vaxcyte, Inc. (PCVX) insiders reported 4 open-market purchases totaling $20.7M and 206 sales totaling $135.3M. That is a net selling position of $114.6M.
How many insiders trade PCVX stock?
17 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Vaxcyte, Inc.. The most recent filing was accepted on Jul 6, 2026.
Where does Trabud get PCVX insider trading data?
All PCVX insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.